Holocene Advisors’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-84,216
Closed -$966K 954
2026
Q1
$966K Buy
+84,216
New +$1.19M ﹤0.01% 672
2025
Q2
Sell
-1,298,942
Closed -$17M 845
2025
Q1
$17M Buy
1,298,942
+173,032
+15% +$2.57M 0.05% 252
2024
Q4
$15.1M Buy
1,125,910
+398,342
+55% +$6.41M 0.05% 273
2024
Q3
$15.4M Sell
727,568
-711,252
-49% -$12.8M 0.06% 218
2024
Q2
$22.8M Buy
1,438,820
+700,008
+95% +$12.9M 0.1% 205
2024
Q1
$11M Buy
+738,812
New +$10.1M 0.04% 268
2022
Q2
Sell
-49,243
Closed -$491K 952
2022
Q1
$491K Buy
+49,243
New +$366K ﹤0.01% 764

Other funds holding OSCR

Holocene Advisors's OSCR Position: Q2 2026 in Review

Holocene Advisors sold out of Oscar Health (OSCR) in Q2 2026, closing a stake of 84,216 shares — an estimated $966K sold.

Holocene Advisors first reported a position in OSCR in Q1 2022 and held it in 7 quarters. The position peaked at $22.8M in Q2 2024. 403 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • Holocene Advisors reported no remaining Oscar Health position as of Q2 2026 after selling out during the quarter.
  • Holocene Advisors sold 84,216 Oscar Health shares in Q2 2026, an estimated $966K.
  • Holocene Advisors first reported a position in Oscar Health in Q1 2022 and held it in 7 quarters.
  • Holocene Advisors's Oscar Health position peaked at $22.8M in Q2 2024.
  • 403 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Holocene Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.